Clinical Trial Update: Low Remifentanil Target Controlled Infusions for Cardiac Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating low remifentanil target-controlled infusions for cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery

Drugs mentioned

• Remifentanil (remifentanil)

Snippet

Sponsor: Imam Abdulrahman Bin Faisal University | Conditions: Cardiac Surgery | Phase 3 | Status: COMPLETED